Ticker brief
VRTX VERTEX PHARMACEUTICALS INC
Consumer, Non-cyclical · Biotechnology
last close
$528.04
1 day
+6.0%
14 days
+16.9%
mkt cap
$134.0B
signals 14d
26
authors 14d
20
Sentiment — last 14 days
daily mean sentiment, 2026-06-21 → 2026-07-03 · now +0.45 (−1 bearish … +1 bullish)
Who spoke20
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @adamfeuerstein | A | +1.05 | 3 | -0.02 |
| @KunnuInvests | C | -0.40 | 3 | +0.58 |
| @ralliesarena | C | -1.81 | 2 | +0.05 |
| @afortunetrading | C | +0.44 | 2 | +0.35 |
| @TheMarket_Monk | C | -1.53 | 1 | +0.35 |
| @RachelDashCS | C | -0.27 | 1 | +0.55 |
| @PolarizingLit | C | +0.26 | 1 | +0.55 |
| @DonDrapperr | B | +0.40 | 1 | +0.35 |
| @PersimmonTI | A | -0.32 | 1 | +0.00 |
| @JaguarAnalytics | B | +0.01 | 1 | +0.35 |
| @BioStocks | C | -0.39 | 1 | +0.55 |
| @InvestmentGuru_ | C | +0.03 | 1 | +0.35 |
| @AlertsAndNews | C | +1.52 | 1 | +0.50 |
| @EmmanuelInvest | C | -1.12 | 1 | +0.55 |
| @MartyChargin | C | -0.72 | 1 | +0.50 |
| @TheProfInvestor | C | +0.27 | 1 | +0.45 |
| @BiopharmIQ | B | · | 1 | +0.50 |
| @TWFeditor | C | +0.57 | 1 | +0.30 |
| @fj_nextstage | C | +1.07 | 1 | +0.15 |
| @AsafNaamani | C | -2.11 | 1 | +0.45 |
Recent signals26of 26 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-03 | @AsafNaamani | +0.45 | Healthcare recap lists breakouts, bases and retests across sector names. | — | tweet ↗ |
| 2026-07-02 | @fj_nextstage | +0.15 | MarketSurge breakout and pivot watch list with IBD exposure reduced. | — | tweet ↗ |
| 2026-07-02 | @KunnuInvests | +0.65 | VRTX breakout confirmed with volume; author says send it higher. | — | tweet ↗ |
| 2026-07-02 | @TWFeditor | +0.30 | Says rotation helps VRTX recover for biotech ETF holders. | — | tweet ↗ |
| 2026-07-02 | @BiopharmIQ | +0.50 | Biotech catalyst roundup cites clinical data, approval, FDA news, and financing. | — | tweet ↗ |
| 2026-07-02 | @TheProfInvestor | +0.45 | Calls for positioning in leading healthcare and banks amid rotation. | — | tweet ↗ |
| 2026-07-02 | @afortunetrading | +0.35 | Cites relative strength and rotation from SMH stocks into software and healthcare. | — | tweet ↗ |
| 2026-07-02 | @adamfeuerstein | -0.10 | Genetix CEO claims leadership in sickle cell gene therapy, with peers mentioned. | — | tweet ↗ |
| 2026-07-02 | @adamfeuerstein | -0.25 | Genetix CEO criticizes Casgevy and Beam effort; author notes no proof. | — | tweet ↗ |
| 2026-07-02 | @MartyChargin | +0.50 | FDA approved expanded CASGEVY use to children ages 2 and older. | — | tweet ↗ |
| 2026-07-01 | @EmmanuelInvest | +0.55 | Vertex received FDA approval expanding CASGEVY to children age 2+ with SCD or TDT. | +6.0% | tweet ↗ |
| 2026-07-01 | @AlertsAndNews | +0.50 | Vertex announces US FDA approval for expanded CASGEVY use. | +6.0% | tweet ↗ |
| 2026-07-01 | @InvestmentGuru_ | +0.35 | Bullish biotech watchlist and long-term sector rotation thesis. | +6.0% | tweet ↗ |
| 2026-07-01 | @BioStocks | +0.55 | FDA approves first gene therapy for young children with SCD. | +6.0% | tweet ↗ |
| 2026-06-30 | @KunnuInvests | +0.65 | Will buy VRTX pullback or breakout — Author says VRTX has bullish HTF setup and will buy pullback or breakout. | +6.3% | tweet ↗ |
| 2026-06-28 | @JaguarAnalytics | +0.35 | Says large pharma names have all been rocket ships lately. | +7.5% | tweet ↗ |
| 2026-06-28 | @PersimmonTI | +0.00 | Shares Nature Medicine piece on late-stage and approved kidney disease therapies. | +7.5% | tweet ↗ |
| 2026-06-26 | @DonDrapperr | +0.35 | Bullish framework for defensive healthcare names during Nasdaq weakness. | +7.5% | tweet ↗ |
| 2026-06-26 | @afortunetrading | +0.35 | Lists relative-strength names and says IBB/XBI sector looks good. | +7.5% | tweet ↗ |
| 2026-06-25 | @KunnuInvests | +0.45 | Author is already riding LLY from $907 and likes VRTX and CAH charts. | +10.0% | tweet ↗ |
| 2026-06-25 | @ralliesarena | +0.00 | Gemini trimmed its Vertex holdings in an AI arena portfolio. | +10.0% | tweet ↗ |
| 2026-06-25 | @PolarizingLit | +0.55 | Reports gene therapy functionally cures a sickle-cell patient. | +10.0% | tweet ↗ |
| 2026-06-23 | @RachelDashCS | +0.55 | Lists chart patterns, support/resistance and measured moves for PGR, SPGI, VRTX and SYK. | +12.7% | tweet ↗ |
| 2026-06-22 | @TheMarket_Monk | +0.35 | Lists stocks with bullish weekly EMA stack as possible watchlist names. | +13.1% | tweet ↗ |
| 2026-06-21 | @adamfeuerstein | +0.30 | Author says Vertex matured into a sustainable biotech with profits and cash flow. | +16.9% | tweet ↗ |
| 2026-06-21 | @ralliesarena | +0.10 | Discloses Gemini AI portfolio holdings and dollar allocations, capped at six tickers. | +16.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.